Cerebion 60 mg Infusion belongs to a group of medicines called central nervous system agents/neuroprotective agents, used to protect the nerves from damage and improve their survival due to various reasons such as for amelioration of cranial injury (head injury), cerebrovascular pathological sequelae and aprosexia in dementia.
Cerebion 60 mg Infusion comprises Cerebroprotein Hydrolysate, a neurotrophic agent, which acts on the central nervous system in various ways to protect neurons and improve memory, attention, and vigilance.
Cerebion 60 mg Infusion will be administered by a qualified healthcare professional. In some cases, you may experience certain common side effects, such as headache, nausea, vertigo, agitation, increased sweating, fever, confusion, hallucinations, and flu-like syndrome. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Keep your doctor informed about your health condition and medicines to rule out any side effects. Cerebion 60 mg Infusion is restricted to use in people who are sensitive to any of the product constituents or people with status epilepticus (continuous state of seizure), major epilepsia (epilepsy) and severe renal dysfunction. During pregnancy and lactation, Cerebroprotein hydrolysate should only be used after careful risk/benefit considerations, so before taking Cerebion 60 mg Infusion, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Cerebion 60 mg Infusion may impair your ability to make judgements, think clearly, or respond fast. Do not drive, operate heavy machinery, or engage in any other risky activity. Avoid consuming alcohol with Cerebion 60 mg Infusion as it could lead to increased drowsiness and dizziness.